Clinical Trial Update: Melphalan and Whole-Body Hyperthermia in Treating Patients With Advanced Melanoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating melphalan with whole-body hyperthermia in patients with advanced melanoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Melphalan (Melphalan)

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Melanoma (Skin) | Phase 2 | Status: COMPLETED